Das Sana Klinikum Hameln-Pyrmont ist ein Krankenhaus in der Stadt Hameln in Niedersachsen. Es verfügt über einen Hubschrauberlandeplatz und ist Notarztstandort.

During the past decade, Kreiskrankenhaus Hameln conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kreiskrankenhaus Hameln" #1 sponsor was "AGO Research GmbH" with 1 trials, followed by "Charite University, Berlin, Germany" with 1 trials sponsored, "NSABP Foundation Inc" with 1 trials sponsored, "Prof. Wolfgang Janni" with 1 trials sponsored and "Spanish Breast Cancer Research Group" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kreiskrankenhaus Hameln" #1 collaborator was "Hoffmann-La Roche" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator and "Cancer International Research Group (CIRG)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Kreiskrankenhaus Hameln" are "Breast Cancer" (2 trials), "HER2-negative Metastatic Breast Cancer" (1 trials), "Hormone Receptor-positive Metastatic Breast Cancer" (1 trials), "Malnutrition" (1 trials) and "Recurrent Platinum-sensitive Ovarian Cancer" (1 trials). Many other conditions were trialed in "Kreiskrankenhaus Hameln" in a lesser frequency.

Most popular intervention types in "Kreiskrankenhaus Hameln" are "Drug" (4 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (3 trials), "Carboplatin" (2 trials), "5-Fluorouracil" (1 trials), "Abemaciclib + Aromatase Inhibitor" (1 trials) and "Abemaciclib + Fulvestrant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kreiskrankenhaus Hameln" are 4 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Kreiskrankenhaus Hameln". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Kreiskrankenhaus Hameln, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kreiskrankenhaus Hameln, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".